4
Changes in Ownership
RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-037582
Chief Financial Officer sold 50,000 shares at an average $10.00 ($500,145)
- Chief Financial Officer acquired 75,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Secora Michael · Chief Financial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-06-13 | Exercise or conversion : show line 1 in the form 10b5-1 | +37,500 | $2.22 | $83,250 | 830,413 | D |
| 2023-06-13 | Sale : show line 2 in the form 10b5-1 | −25,000 | $9.93 | $248,308 | 805,413 | D |
| 2023-06-14 | Exercise or conversion : show line 3 in the form 10b5-1 | +37,500 | $2.22 | $83,250 | 842,913 | D |
| 2023-06-14 | Sale : show line 4 in the form 10b5-1 | −25,000 | $10.07 | $251,838 | 817,913 | D |
| Open-market sales · 50,000 sh · avg $10.00 · $500,145 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-06-13 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) | −37,500 | $2.22 | 2030-03-03 | 37,500 | 782,813 | D |
| 2023-06-14 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | −37,500 | $2.22 | 2030-03-03 | 37,500 | 745,313 | D |
Loading xslF345X04/doc4.xml…